Description: Critical illness insurance is a popular supplemental health insurance product in the U.S. market. This article discusses how carriers have recently sought to add value by expanded the benefits offered in their critical illness products. Specifically, the article discusses the consumer need and development considerations of adding benefits for autism Spectrum Disorder, Mental health disorders, Specified Disease Coverage, and enhance Cancer Coverage to a critical illness contract.

Description: Feature article with helpful hints on video conferencing and more!

Description: Discussion of recent developments in the taxation of noncoordinated benefits such as fixed indemnity, hospital indemnity, and specified disease insurance policies. Developments include a recent Chief Counsel Advice Memorandum and proposed triagency rulemaking that would impact non coordinated benefits.

Description: The last three decades have witnessed an important rise in number of people with diabetes in Asia, especially Type 2 Diabetes. Like no other common condition, numerous innovations are currently entering the healthcare system that will soon have a significant impact on management of the condition. This presentation explores the role played by sensors/wearables, artificial intelligence, new drugs and diabetes apps. We assess the realistic potential of such advancements and give an outlook on medium-term pricing and product development.

Description: This article provides an overview of critical illness insurance: history, product description, and the three primary ways to offer critical illness coverage in the United States. This article also contains an illustration of an issue age premium rate calculation, as well as product features and rating applications specific to the various types of critical illness coverage.

Description: This article discusses the design and pricing of Critical Illness insurance policies.

Description: This session provides an overview of industry approaches to valuing the liabilities of nontraditional health products. Liabilities for losses that have been incurred but not reported and for losses that have been reported but not paid are examined. Includes a discussion on employer specific stop-loss, provider excess loss, critical illness and cancer insurance. From the Record of the Society of Actuaries, Volume 28, No. 2, Session 133

Description: This article announces the following reports on AIDS available from The Canadian Institute of Actuaries: 1. Memorandum covering AIDS from the Chairman of the Committee on Life Insurance Company Financial Reporting, 2. 1988 Guidance Notes for Valuation Actuaries, Report of the Subcommittee on Valuation, Task Force on AIDS, 3. First Report of the Subcommittee on Modeling, Task Force on AIDS, and 4. Second Report of the Subcommittee on Modeling, Task Force on AIDS, An Analysis of USA Data.

Description: In an effort to build a bridge between epidemiological and actuarial modeling, this paper analyzes possible financial arrangements made against expenses resulted from medical treatments given to insured patients. Based on classical compartment models, the first part of this paper designs insurance policies for susceptible participants facing the risk of infection and formulates the financial obligations of both parties using actuarial methodology. For practical purposes, the second part employs a variety of numerical methods for calculating premiums and reserves. The last part illustrates the methods by designing insurance products for the Great Plague in Eyam and the SARS Epidemic in Hong Kong.

Description: Panelists examine various types of critical illness plans, its success in Canada and other markets, and the challenges and opportunities for the U.S. market.